Search

Every New FDA Drug Approval in 2017

EVERY NEW FDA DRUG APPROVAL IN 2017

2017 was a busy year for the FDA. With 46 approvals, the year far outpaced the 22 approvals in 2016. We've already shown you every...

 
 
 

USING AN OLD MERCK DRUG, MENLO HOPES TO SCRATCH AN ITCH WITH $98M IPO

Six months after getting off a $50 million series C, late-stage California dermatology biotech Menlo Therapeutics is looking to take...

MERCK SERONO, WUXI APPTEC AND PONTIFAX FORM ISRAELI LIFE SCIENCE INCUBATOR

The incubator will be located at Merck Serono's current facilities in Yavne, a town in central Israel.

 
 
 
 
 
 
Prognos raises $20.5 million from investors including Cigna, Merck Global Health Innovation Fund

PROGNOS RAISES $20.5 MILLION FROM INVESTORS INCLUDING CIGNA, MERCK GLOBAL HEALTH INNOVATION FUND

Prognos, a New York City-based artificial intelligence company, has wrapped up a $20.5 million Series C financing round from investors...

First Video Game Therapy Heads to FDA As Akili Touts ADHD Study Win

FIRST VIDEO GAME THERAPY HEADS TO FDA AS AKILI TOUTS ADHD STUDY WIN

For the first time ever, a mobile video game used to assess and treat a disease is headed for an FDA review. Akili Interactive Labs,...

 
 
 
Bio Roundup: Migraine Data, Cancer Drug Combos, Azar Hearing & More

BIO ROUNDUP: MIGRAINE DATA, CANCER DRUG COMBOS, AZAR HEARING & MORE

A pair of migraine drugs made a splash in biotech news this week with published data suggesting that they can reduce the frequency...

Chemo Tops Pfizer, Merck KGaA Drug in Big Stomach Cancer Test

CHEMO TOPS PFIZER, MERCK KGAA DRUG IN BIG STOMACH CANCER TEST

Pfizer and Merck KGaA's bid to have a stomach cancer treatment that could leapfrog rival immunotherapies has fallen short. The companies...

 
 
 

THE TOP 10 HIT PARADE OF BIOPHARMA LICENSING DEALS FOR 2014-2017

The Merck KGaA logo stands illuminated at dusk outside the pharmaceutical company's headquarters in Darmstadt, Germany, on November...

Roche Gains Ground on Rivals With Drug Combo's Success in Lung Cancer

ROCHE GAINS GROUND ON RIVALS WITH DRUG COMBO'S SUCCESS IN LUNG CANCER

Roche/Genentech reported this morning that its cancer immunotherapy drug, atezolizumab , has succeeded in a clinical study that could...

 
 
 
X4 Pharma Pulls In $27M for Immune Drug in Cancer, Rare Diseases

X4 PHARMA PULLS IN $27M FOR IMMUNE DRUG IN CANCER, RARE DISEASES

The immune system can't fight disease if its cells don't reach their targets. In some cancers and rare immune deficiency disorders,...

 
 
 
Five Prime Shares Dive on Latest Hiccup For Cancer Immunotherapy Combos

FIVE PRIME SHARES DIVE ON LATEST HICCUP FOR CANCER IMMUNOTHERAPY COMBOS

Another prospective combination of cancer immunotherapy drugs has shown its warts in clinical testing. The latest example: an experimental...

 
 
 
Merck Abandons Plans to Seek FDA Approval of Cholesterol Drug

MERCK ABANDONS PLANS TO SEEK FDA APPROVAL OF CHOLESTEROL DRUG

Merck is pulling the plug on a cholesterol-lowering drug that met its main goal in a clinical trial but still raised questions about...

KalVista, Merck Partnership on Blindness Drug Sends Shares Skyward

KALVISTA, MERCK PARTNERSHIP ON BLINDNESS DRUG SENDS SHARES SKYWARD

KalVista Pharmaceuticals has inked a partnership with pharmaceutical giant Merck for its lead drug, an experimental treatment for a...

 
 
 
Healthcare is Ready for Alexa, as Soon as HIPAA Issue Resolved

HEALTHCARE IS READY FOR ALEXA, AS SOON AS HIPAA ISSUE RESOLVED

A voice-enabled bathroom scale that can scan for diabetic foot ulcers uses Amazon's voice service, Alexa, to instruct patients to step...